Earnings History Data for Cytosorbents Corporation (CTSO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cytosorbents Corporation

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-08-2023	AH		CTSO	Cytosorbents Corporation	163.51	-0.14	-0.11	-0.25	Cytosorbents GAAP EPS of -$0.14 in-line, revenue of $9.4M misses by $0.8M [8/1/2023 4:33 PM]	3.42	-0.21 (-5.66%)	3.60	-0.02 (-0.55%)	1.03 - 4.59	146,261	50,000	600
Cytosorbents GAAP EPS of -$0.14 in-line, revenue of $9.4M misses by $0.8M [8/1/2023 4:33 PM]
02-05-2023	AH	4:15 PM ET (May 2)	CTSO	Cytosorbents Corporation	108.13	-0.17	-0.13	-0.21	Cytosorbents GAAP EPS of -$0.17 misses by $0.02, revenue of $9.44M beats by $0.71M [5/2/2023 4:21 PM]	2.80	0.43 (18.14%)	0.0	0.0 (0.00%)	1.03 - 4.59	140,248	90,000	0
Cytosorbents GAAP EPS of -$0.17 misses by $0.02, revenue of $9.44M beats by $0.71M [5/2/2023 4:21 PM]
09-03-2023	AH	4:15 PM ET (Mar 9)	CTSO	Cytosorbents Corporation	145.31	-0.01	-0.17	-0.21	Cytosorbents GAAP EPS of -$0.75 beats by $0.14, revenue of $29.36M misses by $4.69M [3/9/2023 4:20 PM]	3.56	-0.02 (-0.70%)	0.0	0.0 (0.00%)	1.03 - 4.59	58,980	110,000	0
Cytosorbents GAAP EPS of -$0.75 beats by $0.14, revenue of $29.36M misses by $4.69M [3/9/2023 4:20 PM]
03-11-2022	AH	4:15 PM ET (Nov 3)	CTSO	Cytosorbents Corporation	82.36	-0.28	-0.16	-0.15	Cytosorbents GAAP EPS of -$0.28 misses by $0.12, revenue of $8.1M misses by $0.42M [11/3/2022 5:02 PM]	1.64	-0.31 (-15.89%)	1.68	-0.27 (-13.85%)	1.18 - 6.64	375,754	460,000	53,308
Cytosorbents GAAP EPS of -$0.28 misses by $0.12, revenue of $8.1M misses by $0.42M [11/3/2022 5:02 PM] 'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals [Nov-02-22 07:10AM] CytoSorbents Reports Third Quarter 2022 Financial and Operational Results [Nov-03-22 04:15PM] CytoSorbents (CTSO) Reports Q3 Loss, Misses Revenue Estimates [Nov-03-22 08:15PM]
02-08-2022	AH	4:15 PM ET (Aug 2)	CTSO	Cytosorbents Corporation	92.79	-0.25	-0.14	-0.11	Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M [8/2/2022 4:44 PM]	2.00	-0.33 (-14.32%)	2.32	-0.02 (-0.85%)	1.69 - 9.80	347,477	60,000	225
Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M [8/2/2022 4:44 PM] CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms [Aug-02-22 04:17PM] CytoSorbents Reports Second Quarter 2022 Financial and Operational Results [Aug-02-22 04:15PM] CytoSorbents (CTSO) Reports Q2 Loss, Lags Revenue Estimates [Aug-02-22 06:35PM]
03-05-2022	AH	4:15 PM ET (May 3)	CTSO	Cytosorbents	89.00	-0.21	-0.15	0.00	Cytosorbents GAAP EPS of -$0.21 misses by $0.06, revenue of $8.69M misses by $1.32M [5/3/2022 4:35 PM]	2.11	-0.07 (-3.21%)	1.98	-0.20 (-9.17%)	1.80 - 9.80	507,584	290,000	22,287
Cytosorbents GAAP EPS of -$0.21 misses by $0.06, revenue of $8.69M misses by $1.32M [5/3/2022 4:35 PM] CytoSorbents stock slumps as Q1 revenue falls 18% Y/Y [5/4/2022 11:50 AM] CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany [May-02-22 07:00AM] CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook [May-03-22 04:15PM]
08-03-2022	AH	4:15 PM ET (Mar 8)	CTSO	Cytosorbents Corporation	168.69	-0.21	-0.13	0.00	Cytosorbents reports Q4 results [3/8/2022 4:37 PM]	3.37	-0.38 (-10.13%)	3.60	-0.15 (-4.00%)	3.18 - 9.80	148,854	150,000	24,470
Cytosorbents reports Q4 results [3/8/2022 4:37 PM] CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook [Mar-08-22 04:15PM]
04-11-2021	AH	4:15 PM ET (Nov 4)	CTSO	Cytosorbents Corporation	252.47	-0.15	-0.11	-0.02	Cytosorbents EPS misses by $0.03, beats on revenue [11/4/2021 4:29 PM]	6.25	0.14 (2.29%)	6.25	0.14 (2.29%)	5.73 - 11.68	314,316	180,000	1,442
Cytosorbents EPS misses by $0.03, beats on revenue [11/4/2021 4:29 PM] CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results [Nov-04-21 04:15PM]
03-08-2021	AH	4:15 PM ET (Aug 3)	CTSO	Cytosorbents Corporation	328.43	-0.11	-0.03	-0.08	Cytosorbents EPS misses by $0.06, beats on revenue [8/3/2021 4:35 PM]	7.01	-0.24 (-3.37%)	7.30	0.04 (0.55%)	7.01 - 11.68	211,509	150,000	388
Cytosorbents EPS misses by $0.06, beats on revenue [8/3/2021 4:35 PM] Could The Cytosorbents Corporation (NASDAQ:CTSO) Ownership Structure Tell Us Something Useful? [Aug-03-21 02:56AM] CytoSorbents Reports Second Quarter 2021 Financial and Operational Results [Aug-03-21 04:15PM] CytoSorbents Q2 Earnings Lag Consensus, Higher Costs Weigh On Bottom Line [Aug-04-21 07:00AM]
04-05-2021	AH	4:15 PM ET (May 4)	CTSO	Cytosorbents Corporation	392.74	-0.10	-0.03	-0.10	Cytosorbents EPS misses by $0.05, misses on revenue [5/4/2021 4:33 PM]	8.70	-0.39 (-4.29%)	8.50	-0.59 (-6.49%)	7.13 - 11.74	450,129	220,000	7,639
Cytosorbents EPS misses by $0.05, misses on revenue [5/4/2021 4:33 PM] CytoSorbents Corp. to Host Earnings Call [May-04-21 02:45PM] CytoSorbents Reports First Quarter 2021 Financial and Operational Results [May-04-21 04:15PM]
09-03-2021	AH	4:15 PM ET (Mar 9)	CTSO	Cytosorbents Corporation	370.29	N/A	-0.04	-0.13	Cytosorbents EPS beats by $0.03, beats on revenue [3/9/2021 4:21 PM]	8.56	-0.19 (-2.17%)	9.15	0.40 (4.57%)	3.60 - 11.74	306,589	296,352	259
Cytosorbents EPS beats by $0.03, beats on revenue [3/9/2021 4:21 PM] CytoSorbents's Earnings Outlook [Mar-08-21 10:10AM] CytoSorbents Corp. to Host Earnings Call [Mar-09-21 01:45PM] CytoSorbents Announces 2020 Financial and Operational Results [Mar-09-21 04:15PM] CytoSorbents: Q4 Earnings Insights [Mar-09-21 04:28PM]
04-11-2020	AH	4:15 PM ET (Nov 4)	CTSO	Cytosorbents Corporation	346.99	-0.02	-0.09	-0.21	Cytosorbents EPS beats by $0.07, beats on revenue [11/4/2020 4:23 PM]	8.92	0.53 (6.32%)	8.90	0.51 (6.08%)	3.49 - 11.74	460,890	282,170	5,325

04-08-2020	AH	4:15 PM ET (Aug 4)	CTSO	Cytosorbents Corporation	411.47	-0.08	-0.08	-0.11	Cytosorbents EPS in-line, misses on revenue [8/4/2020 4:33 PM]	9.94	0.53 (5.63%)	9.30	-0.11 (-1.17%)	3.49 - 11.74	425,265	1,012,793	139

05-05-2020	AH	4:15 PM ET (May 5)	CTSO	Cytosorbents Corporation	311.42	-0.10	-0.14	-0.15	Cytosorbents EPS beats by $0.05, beats on revenue [5/5/2020 4:19 PM]	9.31	-0.07 (-0.75%)	10.10	0.79 (8.49%)	3.49 - 10.24	471,069	835,146	9,333